Study on comparing the effectiveness of pericapsular nerve group block between ropivacaine and ropivacaine with dexmedetomidine in patients with hip fractures.

Not yet recruiting

• Conditions: Other specified acquired deformities of musculoskeletal system,

• Registration Number: CTRI/2023/12/060779
• Lead Sponsor: Dr k. Jeyanthi

Brief Summary

The study is a double blinded randomised control study to compare the analgesic effectiveness of Pericapsular nerve group (PENG) block with ropivacaine vs ropivacaine with dexmedetomidine in patients with hip fractures.The study will be conducted on patients above 18 years of age and belonging to ASA 1,2,3 with hip fractures

The study will be conducted for a period of 18 months in patients with hip fractures coming to Sri Venkateshwaraa medical college ,hospital and research centre .The primary objective is to compare the onset of pain relief and reduction in pain score(VAS) during the positioning of patients for central neuraxial blockade between the two groups.

The secondary objective is to access  the duration of post operative pain relief in both groups and to access the total analgesic requirements for 24 hours.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-12-19
• Study Start: 2023-12-29

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Patients belonging to ASA grade 1,2 and 3 with hip fractures, posted for surgery under spinal anaesthesia who are unable to sit due to pain in the hip joint.
• Patients of either sex above 18 years of age.

Exclusion Criteria

• Patients with hemorrhagic diasthesis, neurocognitive disorders,spinal deformities, psychiatric disorders.
• Patients with allergy to study drug.
• Patients with polytrauma, infection over injected site.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare the onset of pain relief & reduction in pain score(VAS)during the positioning of patients for central neuraxial blockade with 0.25% ropivacaine 20ml and 0.25% ropivacaine 20ml and dexmedetomidine 25 mcg	duration of onset of pain relief will be noted at 5,10,15,20,30 minutes after the block

Secondary Outcome Measures

Name	Time	Method
To assess the duration of post operative pain relief in both groups & to assess the total analgesic requirements for 24 hours	18 months

Trial Locations

Locations (1)

Sri Venkateshwaraa medical college, hospital and research centre; 🇮🇳 Pondicherry, PONDICHERRY, India

Sri Venkateshwaraa medical college, hospital and research centre

🇮🇳Pondicherry, PONDICHERRY, India

Jeyanthi

Principal investigator

9600817648

jeyanthik97@gmail.com